Back Bay Life Science Advisors

Back Bay is the only life sciences group that integrates seasoned strategic insight with investment banking capabilities to provide comprehensive guidance to global life sciences companies and their investors Our team has the expertise to advise clients through complex business, scientific and financial challenges

Boutique Feel + Global Reach

Global biotech Pharmaceutical Medical Device Companies Investors Academic centers of technology development Government incubators These are the organizations that rely on Back Bay for strategic guidance and responsive client service across their commercial, R&D, corporate business development and investment banking opportunities in the US and around the world

We’re pleased to provide a snapshot of some of our recent transactions and projects

View More on Transaction Highlights > Searching for a Career? Meet Us on Campus Throughout September, Back Bay Life Science Advisors' strategic advisory and investment teams will be on campus speaking with students interested in a career in life sciences development

Find Out More Information >

Back Bay advisors are trusted partners who combine insights generated from in-depth scientific, clinical and financial analysis with exceptional transaction execution capabilities. The result is tailored advice for every phase of the product life cycle.

600+ Projects in Biopharma and Medtech

Actionable Life Sciences Solutions

Life Sciences Development and Commercialization

We guide biotech, pharmaceutical and medical technology companies and their investors on the development, commercialization, growth and maintenance of market share, by providing the insight needed to drive growth and create value Together we can capitalize on opportunity, increase shareholder value and improve patient care

Latest Back Bay White Papers on Biopharma, MedTech Commercialization and Transactions

View our Transaction Highlights

This past year has been one of tremendous growth and progress for Back Bay Life Science Advisors We served as advisors to global biopharma and medtech companies, guided them as they navigated the complexities and scientific and transactional challenges of bringing new treatments to the market and continued our work of paving a way toward the next generation of life science breakthroughs We are proud to present this snapshot of our project work and transaction highlights from 2021

Visit Our Library of Industry Articles and White Papers >>